XENE
Xenon Pharmaceuticals Inc
57.40$
+1.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | – | – | – | – | – | – | |
| – | 15.8% | – | – | – | 25.2% | – | – | – | – | – | – | – | |
| – | 84.2% | – | – | – | 50.0% | 100.0% | – | – | – | – | – | – | |
| – | 763.5% | – | – | – | 2,363.8% | 816.0% | – | – | – | – | – | – | |
| – | 234.6% | – | – | – | 715.6% | 253.8% | – | – | – | – | – | – | |
| – | 998.0% | – | – | – | 3,079.4% | 1,069.8% | – | – | – | – | – | – | |
| – | -998.0% | – | – | – | -3,079.4% | -969.8% | – | – | – | – | – | – | |
| – | 141.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -835.5% | – | – | – | -2,763.6% | -861.6% | – | – | – | – | – | – | |
| – | -3.8% | – | – | – | -152.9% | 5.7% | – | – | – | – | – | – | |
| – | -831.7% | – | – | – | -2,610.7% | -867.3% | – | – | – | – | – | – | |
| – | -982.2% | – | – | – | -3,054.2% | -961.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.